Deutsche Bank Maintains Hold on Teladoc Health, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst George Hill maintains a Hold rating on Teladoc Health and raises the price target from $10 to $12.
November 01, 2024 | 5:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank has maintained its Hold rating on Teladoc Health and increased the price target from $10 to $12, indicating a slightly more positive outlook.
The increase in price target from $10 to $12 by Deutsche Bank suggests a slightly improved outlook for Teladoc Health, which could positively influence investor sentiment and potentially lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100